ID

44442

Description

This CRF is set up in modules to be used for recording data on the ISARIC COVID-19 Core Database or for independent studies. Module 1 and Module 2 complete on the first day of presentation/admission or on first day of COVID-19 assessment. Module 2 also complete on first day of admission to ICU or high dependency unit. In addition, complete daily for as many days as resources allow up to a maximum of 14 days. Continue to follow-up patients who transfer between wards. Module 3 (Outcome) complete at discharge or death General Guidance: - The CRF is designed to collect data obtained through examination, interview and review of hospital notes. Data may be collected retrospectively if the patient is enrolled after the admission date. - For more detailed guidance on how to complete these forms, please refer to the CRF Completion Guideline - Participant Identification Numbers consist of a 3 digit site code and a 4 digit participant number. You can obtain a site code and registering on the data management system by contacting ISARIC. Participant numbers should be assigned sequentially for each site beginning with 0001. In the case of a single site recruiting participants on different wards, or where it is otherwise difficult to assign sequential numbers, it is acceptable to assign numbers in blocks or incorporating alpha characters. E.g. Ward X will assign numbers from 0001 or A001 onwards and Ward Y will assign numbers from 5001 or B001 onwards. Enter the Participant Identification Number at the top of every page. - Printed paper CRFs may be used for later transfer of the data onto the electronic database. - For participants who return for re-admission to the same site, start a new form with a different Participant Identification Number. Please check “YES-admitted previously” in the ONSET & ADMISSION section. Enter as 2 separate entries in the electronic database. - For participants who transfer between two sites that are both collecting data on this form, it is preferred to have the data entered by a single site as a single admission, under the same Participant Identification Number. When this is not possible, the first site should record “Transfer to other facility” as an OUTCOME, and the second site should start a new form with a new patient number and indicate “YES-transferred” in ONSET & ADMISSION. - Complete every line of every section, except for where the instructions say to skip a section based on certain responses. - Mark ‘Not done’ for any results of laboratory values that are not available, not applicable or unknown. - Avoid recording data outside of the dedicated areas. Sections are available for recording additional information. - If using paper CRFs, we recommend writing clearly in ink, using BLOCK-CAPITAL LETTERS. - Place an (X) when you choose the corresponding answer. To make corrections, strike through (-------) the data you wish to delete and write the correct data above it. Please initial and date all corrections. - Please keep all of the sheets for a single participant together e.g. with a staple or participant-unique folder. - ISARIC would like the centers to enter data directly into their electronic data capture system. Please contact ISARIC about access. If your site would like to collect data independently, ISARIC can support you in the estabilishment of locally hosted databases. This version may serve as a basis for locally hosted databases. - Please contact ISARIC, if you need help with databases, have comments or to let ISARIC know that you are using the CRF. - Please let us know if you find any mistakes in the MDM Portal's version. FURTHER GUIDANCE AND DEFINITIONS (from the Completion guideline) Comorbidities: Comorbidities present before the onset of COVID-19 and are still present. Do not include those that developed following the onset of COVID-19 symptoms. More detailed guidance is provided. Hospital admission: For patients who were admitted to hospital with COVID-19 or symptoms consistent with possible COVID-19 infection, please enter details for the date of hospital admission. For patients with a clear alternative diagnosis leading to admission who subsequently acquired COVID-19, original admission date should be provided, but all subsequent references to admission should be taken as referring to day COVID-19 was first clinically suspected (or within the first 24 hours after first day of suspected or confirmed COVID-19 infection). Where a patient was admitted via multiple hospital departments, count admission from the time they came to the first department during the visit that led to their admission (e.g. arrival at the Emergency Department). Oxygen therapy: Include any form of supplemental oxygen received using any methods. Invasive ventilation: Please include any mechanical ventilation delivered following intubation or via a tracheostomy. Do not include patients who are breathing independently via a tracheostomy. Non-invasive ventilation: Please include any positive-pressure treatment given via a tight-fitted mask. This can be continuous positive pressure (CPAP) or bi-level positive pressure (BIPAP). Renal replacement therapy or dialysis: Please include any form of continuous renal replacement therapy or intermittent haemodialysis. Worst result: References to ‘worst result’ refer to those furthest from the normal physiological range or laboratory normal range. Results that were rejected by the clinical team (e.g. pulse oximetry on poorly perfused extremities, haemolysed blood samples, contaminated microbiology results) should not be reported. The following measures should be considered as a single observation and entered together: Blood gas results: Please report the measures from the blood gas with the lowest pH (most acidotic). Blood pressure: Please report the systolic and diastolic blood pressure from the observation with the lowest mean arterial pressure (if mean arterial pressure has not been calculated, report the measurement with lowest systolic blood pressure). Respiratory rate: If both abnormal low and high rate observed, record the abnormally high rate. General information about ISARIC ISARIC has developed a portfolio of resources to accelerate outbreak research and response. All resources are designed to address the most critical public health questions, have undergone extensive review by international clinical experts, and are free to use. ISARIC should be acknowledged and informed if you implement the protocol. Ethical apporval of the protocol and all necessary operational and financial arrangements are the responsibility of the investigators. This form refers to the CoV CASE RECORD FORM Version 1.3 25 Aug 2020. See https://isaric.tghn.org/COVID-19-CRF/

Lien

https://isaric.tghn.org/COVID-19-CRF/

Mots-clés

  1. 18/01/2021 18/01/2021 -
  2. 20/09/2021 20/09/2021 -
Détendeur de droits

ISARIC on behalf of Oxford University

Téléchargé le

20 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-SA 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

ISARIC/WHO Novel Coronavirus (nCoV) / COVID-19 Case Record Form

MODULE 3: OUTCOME CASE REPORT FORM

Participant Identification
Description

Participant Identification

Alias
UMLS CUI-1
C3165543
Participant Identification Numbers
Description

Participant Identification Numbers consist of a 3 digit site code and a 4 digit participant number. You can obtain a site code and registering on the data management system by contacting ncov@isaric.org. Participant numbers should be assigned sequentially for each site beginning with 0001. In the case of a single site recruiting participants on different wards, or where it is otherwise difficult to assign sequential numbers, it is acceptable to assign numbers in blocks or incorporating alpha characters. E.g. Ward X will assign numbers from 0001 or A001 onwards and Ward Y will assign numbers from 5001 or B001 onwards. Enter the Participant Identification Number at the top of every page.

Type de données

text

Alias
UMLS CUI [1]
C3165543
At ANY time during hospitalisation, did the patient receive/undergo:
Description

At ANY time during hospitalisation, did the patient receive/undergo:

Alias
UMLS CUI-1
C0087111
Any Oxygen therapy?
Description

Complete this field for all patients. If the patient received any form of supplementary oxygen, via nose cannula, mask or non-invasive or invasive ventilation tick ‘yes’ and indicate the total days they received any form of oxygen (O2) therapy. If any supplemental oxygen (at any concentration) was given by any means of delivery at any point during the patient’s hospital stay, place a cross in the box marked ‘yes’. This includes any supplementary oxygen (O2) delivered via non-invasive facemasks/nasal cannula/mask or via invasive mechanical ventilation. Please also indicate the maximum O2 flow volume. If it is not possible to access record of the absolute highest O2 volume delivered during the admission indicate the highest known.

Type de données

integer

Alias
UMLS CUI [1]
C0184633
If YES, total duration:
Description

Complete this field for all patients. If the patient received any form of supplementary oxygen, via nose cannula, mask or non-invasive or invasive ventilation tick ‘yes’ and indicate the total days they received any form of oxygen (O2) therapy. If any supplemental oxygen (at any concentration) was given by any means of delivery at any point during the patient’s hospital stay, place a cross in the box marked ‘yes’. This includes any supplementary oxygen (O2) delivered via non-invasive facemasks/nasal cannula/mask or via invasive mechanical ventilation. Please also indicate the maximum O2 flow volume. If it is not possible to access record of the absolute highest O2 volume delivered during the admission indicate the highest known. For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.

Type de données

integer

Unités de mesure
  • days
Alias
UMLS CUI [1,1]
C0184633
UMLS CUI [1,2]
C0449238
UMLS CUI [1,3]
C2348235
days
Total duration: unknown
Description

Complete this field for all patients. If the patient received any form of supplementary oxygen, via nose cannula, mask or non-invasive or invasive ventilation tick ‘yes’ and indicate the total days they received any form of oxygen (O2) therapy. If any supplemental oxygen (at any concentration) was given by any means of delivery at any point during the patient’s hospital stay, place a cross in the box marked ‘yes’. This includes any supplementary oxygen (O2) delivered via non-invasive facemasks/nasal cannula/mask or via invasive mechanical ventilation. Please also indicate the maximum O2 flow volume. If it is not possible to access record of the absolute highest O2 volume delivered during the admission indicate the highest known.

Type de données

boolean

Alias
UMLS CUI [1,1]
C0184633
UMLS CUI [1,2]
C0449238
UMLS CUI [1,3]
C0439673
Maximum O2 flow volume:
Description

Maximum O2 flow volume

Type de données

integer

Alias
UMLS CUI [1]
C1960999
Non-invasive ventilation? (Any)
Description

If the patient received non-invasive ventilation (NIV), defined as the provision of ventilatory support through the patient's upper airway using a mask or similar device, at any time during their hospital stay, place tick ‘yes’ and enter the total duration in days if known.

Type de données

integer

Alias
UMLS CUI [1]
C1997883
If YES, total duration:
Description

If the patient received non-invasive ventilation (NIV), defined as the provision of ventilatory support through the patient's upper airway using a mask or similar device, at any time during their hospital stay, place tick ‘yes’ and enter the total duration in days if known. For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.

Type de données

integer

Unités de mesure
  • days
Alias
UMLS CUI [1,1]
C1997883
UMLS CUI [1,2]
C0449238
UMLS CUI [1,3]
C2348235
days
Total duration: unknown
Description

If the patient received non-invasive ventilation (NIV), defined as the provision of ventilatory support through the patient's upper airway using a mask or similar device, at any time during their hospital stay, place tick ‘yes’ and enter the total duration in days if known.

Type de données

boolean

Alias
UMLS CUI [1,1]
C1997883
UMLS CUI [1,2]
C0449238
UMLS CUI [1,3]
C0439673
Invasive ventilation (Any)?
Description

Invasive ventilation means that patient has undergone tracheal intubation, for the purpose of invasive mechanical ventilation. Invasive ventilation is a method to mechanically assist or replace spontaneous breathing in patients by use of a powered device that forces oxygenated air into the lungs. The mode of intubation may be orotracheal, nasotracheal, or via a cricothyrotomy or tracheotomy.

Type de données

integer

Alias
UMLS CUI [1]
C1868981
If YES, total duration:
Description

For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.

Type de données

integer

Unités de mesure
  • days
Alias
UMLS CUI [1,1]
C1868981
UMLS CUI [1,2]
C0449238
days
Total duration: unknown
Description

Invasive ventilation means that patient has undergone tracheal intubation, for the purpose of invasive mechanical ventilation. Invasive ventilation is a method to mechanically assist or replace spontaneous breathing in patients by use of a powered device that forces oxygenated air into the lungs. The mode of intubation may be orotracheal, nasotracheal, or via a cricothyrotomy or tracheotomy.

Type de données

boolean

Alias
UMLS CUI [1,1]
C1868981
UMLS CUI [1,2]
C0439673
Prone Positioning?
Description

Prone ventilation refers to ventilation with the patient lying in the prone position. If the patient received prone ventilation at any time during their hospital stay, please tick ‘yes’ and indicate the total duration in days.

Type de données

integer

Alias
UMLS CUI [1,1]
C0808387
UMLS CUI [1,2]
C0033422
If YES, total duration:
Description

Prone ventilation refers to ventilation with the patient lying in the prone position. If the patient received prone ventilation at any time during their hospital stay, please tick ‘yes’ and indicate the total duration in days. For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.

Type de données

integer

Unités de mesure
  • days
Alias
UMLS CUI [1,1]
C0808387
UMLS CUI [1,2]
C0033422
UMLS CUI [1,3]
C0449238
UMLS CUI [1,4]
C2348235
days
Total duration: unknown
Description

Prone ventilation refers to ventilation with the patient lying in the prone position. If the patient received prone ventilation at any time during their hospital stay, please tick ‘yes’ and indicate the total duration in days.

Type de données

boolean

Alias
UMLS CUI [1,1]
C0808387
UMLS CUI [1,2]
C0033422
UMLS CUI [1,3]
C0449238
UMLS CUI [1,4]
C0439673
Inhaled Nitric Oxide?
Description

If the patient received inhaled nitric oxide at any time during their hospital stay, place a cross (X) in the box marked ‘yes’. If they did not, place a cross in the box marked ‘no’. If the answer is not known, place a cross in the box marked ‘N/A’.

Type de données

integer

Alias
UMLS CUI [1]
C1135443
Tracheostomy inserted?
Description

If the patient received a tracheostomy, place a cross (X) in the box marked ‘yes’. If they did not, place a cross in the box marked ‘no’. If the answer is not known, place a cross in the box marked ‘N/A’.

Type de données

integer

Alias
UMLS CUI [1]
C0040590
Extracorporeal support?
Description

Extracorporeal Life Support (ECLS), also known as Extracorporeal membrane oxygenation (ECMO) is a variation of cardiopulmonary bypass, it maintains tissue oxygenation for days to weeks in patients with life threatening respiratory or cardiac failure (or both). N/A’).

Type de données

integer

Alias
UMLS CUI [1]
C4068956
If YES, total duration:
Description

Extracorporeal Life Support (ECLS), also known as Extracorporeal membrane oxygenation (ECMO) is a variation of cardiopulmonary bypass, it maintains tissue oxygenation for days to weeks in patients with life threatening respiratory or cardiac failure (or both). N/A’). For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.

Type de données

integer

Unités de mesure
  • days
Alias
UMLS CUI [1,1]
C4068956
UMLS CUI [1,2]
C0449238
UMLS CUI [1,3]
C2348235
days
Total duration: unknown
Description

Extracorporeal Life Support (ECLS), also known as Extracorporeal membrane oxygenation (ECMO) is a variation of cardiopulmonary bypass, it maintains tissue oxygenation for days to weeks in patients with life threatening respiratory or cardiac failure (or both). N/A’).

Type de données

boolean

Alias
UMLS CUI [1,1]
C4068956
UMLS CUI [1,2]
C0439673
Renal replacement therapy (RRT) or dialysis?
Description

Renal replacement therapy includes haemodialysis, peritoneal dialysis (PD), intermittent haemodialysis (IHD), on-line intermittent haemofiltration (IHF), on-line haemodiafiltration (IHDF), continuous haemofiltration (CHF) and continuous haemodiafiltration (CHDF), continuous venovenous haemofiltration (CVVH), continuous venovenous haemodialysis (CVVHD), continuous venovenous haemodiafiltration (CVVHDF), slow continuous ultrafiltration (SCUF), continuous arteriovenous haemofiltration (CAVHD) and sustained low- efficiency dialysis (SLED).

Type de données

integer

Alias
UMLS CUI [1]
C0206074
UMLS CUI [2]
C0011946
Inotropes/vasopressors?
Description

A vasopressor is a pharmaceutical agent that causes vasoconstriction. Agents include norepinephrine, epinephrine, vasopressin, terlipressin and phenylephrine. An inotrope is a pharmaceutical agent that alters the force of myocardial contractility. Commonly used ‘positive’ inotropes include dobutamine, dopamine, milrinone and adrenaline (epinephrine). If the patient received a vasopressor or inotrope for at least one hour during their hospital stay, place tick ‘yes’ and the total duration in days if known.

Type de données

integer

Alias
UMLS CUI [1]
C0304509
UMLS CUI [2]
C0042397
If YES, total duration:
Description

A vasopressor is a pharmaceutical agent that causes vasoconstriction. Agents include norepinephrine, epinephrine, vasopressin, terlipressin and phenylephrine. An inotrope is a pharmaceutical agent that alters the force of myocardial contractility. Commonly used ‘positive’ inotropes include dobutamine, dopamine, milrinone and adrenaline (epinephrine). If the patient received a vasopressor or inotrope for at least one hour during their hospital stay, place tick ‘yes’ and the total duration in days if known. For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.

Type de données

integer

Unités de mesure
  • days
Alias
UMLS CUI [1,1]
C0042397
UMLS CUI [1,2]
C0449238
UMLS CUI [1,3]
C2348235
UMLS CUI [2,1]
C0304509
UMLS CUI [2,2]
C0449238
UMLS CUI [2,3]
C2348235
days
Total duration: unknown
Description

A vasopressor is a pharmaceutical agent that causes vasoconstriction. Agents include norepinephrine, epinephrine, vasopressin, terlipressin and phenylephrine. An inotrope is a pharmaceutical agent that alters the force of myocardial contractility. Commonly used ‘positive’ inotropes include dobutamine, dopamine, milrinone and adrenaline (epinephrine). If the patient received a vasopressor or inotrope for at least one hour during their hospital stay, place tick ‘yes’ and the total duration in days if known.

Type de données

boolean

Alias
UMLS CUI [1,1]
C0304509
UMLS CUI [1,2]
C0439673
UMLS CUI [2,1]
C0042397
UMLS CUI [2,2]
C0439673
ICU or High Dependency Unit admission?
Description

Place a cross (X) in the appropriate box: yes, (if admitted) or no (if this is not the case).

Type de données

integer

Alias
UMLS CUI [1]
C0583239
UMLS CUI [2]
C1301858
If YES, total duration:
Description

Please enter the total number of days the patient was admitted to the ICU/HDU, this should include all ICU/HDU admissions if there were more than one. Count any day in which the patient was in ICU/HDU during that 24 hour period (please note this number could be significantly shorter than indicated by the two dates indicated in the first and last day field if the patient was discharged to another ward/unit and readmitted to the ICU/HDU during their hospital stay). For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.

Type de données

integer

Unités de mesure
  • days
Alias
UMLS CUI [1,1]
C1627345
UMLS CUI [1,2]
C0444921
UMLS CUI [1,3]
C2348235
UMLS CUI [2,1]
C0021708
UMLS CUI [2,2]
C0444921
UMLS CUI [2,3]
C2348235
days
Total duration: unknown
Description

Please enter the total number of days the patient was admitted to the ICU/HDU, this should include all ICU/HDU admissions if there were more than one. Count any day in which the patient was in ICU/HDU during that 24 hour period (please note this number could be significantly shorter than indicated by the two dates indicated in the first and last day field if the patient was discharged to another ward/unit and readmitted to the ICU/HDU during their hospital stay).

Type de données

boolean

Alias
UMLS CUI [1,1]
C1627345
UMLS CUI [1,2]
C0449238
UMLS CUI [1,3]
C0439673
UMLS CUI [2,1]
C0021708
UMLS CUI [2,2]
C0449238
UMLS CUI [2,3]
C0439673
If YES, date of ICU admission
Description

Date of most recent admission from ICU/ HDU. This section may need to be revised if the patient has more than one ICU/HDU admission during a single hospital admission.

Type de données

date

Alias
UMLS CUI [1,1]
C0583239
UMLS CUI [1,2]
C1302393
UMLS CUI [2,1]
C1301858
UMLS CUI [2,2]
C1302393
Date of ICU admission: unknown
Description

If the answer is YES, please indicate the date on which the patient was first admitted to the intensive care unit / High Dependence Unit (ICU/HDU).

Type de données

boolean

Alias
UMLS CUI [1,1]
C0583239
UMLS CUI [1,2]
C1302393
UMLS CUI [1,3]
C0439673
UMLS CUI [2,1]
C1301858
UMLS CUI [2,2]
C1302393
UMLS CUI [2,3]
C0439673
If YES, date of ICU discharge:
Description

Date of most recent discharge from ICU/ HDU. This section may need to be revised if the patient has more than one ICU/HDU admission during a single hospital admission.

Type de données

date

Alias
UMLS CUI [1,1]
C1627345
UMLS CUI [1,2]
C2361123
UMLS CUI [2,1]
C0021708
UMLS CUI [2,2]
C2361123
Date of ICU discharge: unknown
Description

Date of most recent discharge from ICU/ HDU. This section may need to be revised if the patient has more than one ICU/HDU admission during a single hospital admission.

Type de données

date

Alias
UMLS CUI [1,1]
C1627345
UMLS CUI [1,2]
C2361123
UMLS CUI [1,3]
C0439673
UMLS CUI [2,1]
C0021708
UMLS CUI [2,2]
C2361123
UMLS CUI [2,3]
C0439673
At any time during hospitalisation did the patient experience
Description

At any time during hospitalisation did the patient experience

Alias
UMLS CUI-1
C0009566
Viral pneumonitis
Description

Clinically or radiologically diagnosed viral pneumonitis/pneumonia. For all items in this group: Please select all that were clinically identified at any time during the hospital admission. Do not include known comorbidities (e.g. previous atrial fibrillation should not be included but new onset during this admission should). Record physician diagnosed complications.

Type de données

integer

Alias
UMLS CUI [1]
C0032310
Bacterial pneumonia
Description

Clinically or radiologically diagnosed bacterial pneumonia (including community, hospital and ventilator acquired) managed with antimicrobials. Bacteriological confirmation not required.

Type de données

integer

Alias
UMLS CUI [1]
C0004626
Acute Respiratory Distress Syndrome
Description

Defined according to Berlin criteria as: - Occurring within 1 week of a known clinical insult or worsening respiratory symptoms - Bilateral radiological opacities not fully explained by effusions, lobar/lung collapse, or nodules - Respiratory failure not fully explained by cardiac failure or fluid overload

Type de données

integer

Alias
UMLS CUI [1]
C4534309
If you ticked "Yes" on Acute Respiratory Distress Syndrome, please specify the severity:
Description

Defined according to Berlin criteria as: - Occurring within 1 week of a known clinical insult or worsening respiratory symptoms - Bilateral radiological opacities not fully explained by effusions, lobar/lung collapse, or nodules - Respiratory failure not fully explained by cardiac failure or fluid overload The severity of the hypoxaemia defines the severity of the ARDS: Mild ARDS: The PaO2/FiO2 is >200 mmHg, but ≤300 mmHg, on ventilator settings that include positive end- expiratory pressure (PEEP) or continuous positive airway pressure (CPAP) ≥5 cm H2O. Moderate ARDS: The PaO2/FiO2 is >100 mmHg, but ≤200 mmHg, on ventilator settings that include PEEP ≥5 cm H2O. Severe ARDS: The PaO2/FiO2 is ≤100 mmHg on ventilators setting that include PEEP ≥5 cm H2O. To determine the PaO2/FiO2 ratio, the PaO2 is measured in mmHg and the FiO2 is expressed as a decimal between 0.21 and 1. As an example, if a patient has a PaO2 of 60 mmHg while receiving 60% oxygen, then the PaO2/FiO2 is 60/0.6 = 100 mmHg.

Type de données

integer

Alias
UMLS CUI [1,1]
C4534309
UMLS CUI [1,2]
C0439793
Pneumothorax
Description

Is defined as the abnormal presence of air in the pleural cavity (between the lungs and the chest wall), causing collapse of the lung. It may be diagnosed clinically, usually with radiological confirmation.

Type de données

integer

Alias
UMLS CUI [1]
C0032326
Pleural effusion
Description

Is defined as increased amounts of fluid within the pleural cavity. It may be diagnosed clinically, with or without radiological or interventional confirmation.

Type de données

integer

Alias
UMLS CUI [1]
C1253943
Cryptogenic organizing pneumonia (COP)
Description

Idiopathic diffuse interstitial lung disease, diagnosed radiologically (multiple consolidative or ground glass opacities) or histologically (granulation tissue and chronic inflammatory infiltrate in alveoli). Formerly known as bronchiolitis obliterans organizing pneumonia (BOOP)

Type de données

integer

Alias
UMLS CUI [1]
C0242770
Bronchiolitis
Description

This is a clinical diagnosis.

Type de données

integer

Alias
UMLS CUI [1]
C0006271
Cardiac arrest
Description

Sudden cessation of cardiac activity with no normal breathing and no signs of circulation.

Type de données

integer

Alias
UMLS CUI [1]
C0018790
Myocardial infarction
Description

Myocardial ischaemia (MI) leading to injury/necrosis, diagnosed by clinical findings, altered electrocardiography and elevated cardiac enzymes.

Type de données

integer

Alias
UMLS CUI [1]
C0027051
Cardiac ischaemia
Description

Is defined as diminished blood and oxygen supply to the heart muscle, also known as myocardial ischemia, It is confirmed by an electrocardiogram (showing ischaemic changes, e.g. ST depression or elevation) and/or cardiac enzyme elevation.

Type de données

integer

Alias
UMLS CUI [1]
C0151744
Cardiac arrhythmia
Description

If a cardiac arrhythmia is identified and there is no previous record of it, select ‘yes’.

Type de données

integer

Alias
UMLS CUI [1]
C0003811
Myocarditis / Pericarditis
Description

Myocarditis / pericarditis refers to an inflammation of the heart or pericardium (outer lining of the heart). Diagnosis can be clinical, biochemical (cardiac enzymes) or radiological.

Type de données

integer

Alias
UMLS CUI [1]
C0027059
UMLS CUI [2]
C0031046
Endocarditis
Description

Endocarditis is an inflammation of the endocardium (inner lining of the heart). Diagnosis is according to modified Duke criteria, using evidence from microbiological results, echocardiogram and clinical signs.

Type de données

integer

Alias
UMLS CUI [1]
C0014118
Cardiomyopathy
Description

Structural and functional disorders of myocardium commonly diagnosed by echocardiography. Can be primary (genetic) or secondary (e.g. following myocardial infarction).

Type de données

integer

Alias
UMLS CUI [1]
C0878544
Congestive heart failure
Description

Is defined as failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and oedema.

Type de données

integer

Alias
UMLS CUI [1]
C0018802
Seizure
Description

Select ‘yes’ for any seizure regardless of cause (e.g. febrile or due to epilepsy)

Type de données

integer

Alias
UMLS CUI [1]
C0036572
Stroke / Cerebrovascular accident
Description

Stroke may be a clinical diagnosis, with or without supportive radiological findings.

Type de données

integer

Alias
UMLS CUI [1]
C0038454
Meningitis / Encephalitis
Description

Inflammation of the meninges or the brain parenchyma. Select yes if diagnosed clinically, radiologically or microbiologically.

Type de données

integer

Alias
UMLS CUI [1]
C0497299
Bacteremia
Description

Growth of bacteria on a blood culture. Select ‘no’ if the only bacteria grown were believed to be skin contaminants (e.g. coagulase negative Staphylococci or diphtheroids).

Type de données

integer

Alias
UMLS CUI [1]
C0004610
Coagulation disorder / Disseminated Intravascular Coagulation
Description

Abnormal coagulation identified by abnormal prothrombin time or activated partial thromboplastin time. Disseminated intravascular coagulation (DIC; consumption coagulopathy; defibrination syndrome) is defined by thrombocytopenia, prolonged prothrombin time, low fibrinogen, elevated D-dimer and thrombotic microangiopathy.

Type de données

integer

Alias
UMLS CUI [1]
C0012739
UMLS CUI [2]
C0005779
Pulmonary embolism
Description

Obstruction of pulmonary artery by thrombus, air or fat. Physician diagnosis based on clinical signs, computed tomographic pulmonary angiography and/or ventilation/perfusion scanning.

Type de données

integer

Alias
UMLS CUI [1]
C0034065
Anemia
Description

Select ‘yes’ if haemoglobin levels were lower than age- and sex-specific thresholds listed in https://media.tghn.org/medialibrary/2020/04/ISARIC_nCoV_CRF_Completion_Guide_V1.3_24Feb2020.pdf (Page 15 of 22)

Type de données

integer

Alias
UMLS CUI [1]
C0002871
Rhabdomyolysis / Myositis
Description

Rhabdomyolysis is a syndrome characterised by muscle necrosis and the release of myoglobin into the blood. Muscle biopsy, electromyography, radiological imaging and the presence of myoglobinuria are not required for the diagnosis. Myositis may be a clinical diagnosis with supporting evidence from laboratory tests e.g. elevated serum creatine kinase; histological confirmation is not required to make the diagnosis. Myositis can occur without progression to rhabdomyolysis.

Type de données

integer

Alias
UMLS CUI [1]
C0035410
UMLS CUI [2]
C0027121
Acute renal injury/ Acute renal failure
Description

Acute renal injury is defined as any of: - Increase in serum creatinine by ≥0.3 mg/dL (≥26.5 μmol/L) within 48 hours - Increase in serum creatinine to ≥1.5 times baseline, which is known or presumed to have occurred within the prior 7 days - Urine volume <0.5 mL/kg/hour for 6 hours

Type de données

integer

Alias
UMLS CUI [1]
C0022660
UMLS CUI [2]
C2609414
Gastrointestinal haemorrhage
Description

Refers to bleeding originating from any part of the gastrointestinal tract (from the oropharynx to the rectum).

Type de données

integer

Alias
UMLS CUI [1]
C0017181
Pancreatitis
Description

Inflammation of the pancreas, diagnosed from clinical, biochemical, radiological or histological evidence.

Type de données

integer

Alias
UMLS CUI [1]
C0030305
Liver dysfunction
Description

A finding that indicates abnormal liver function, may refer to any of the following: - Clinical jaundice - Hyperbilirubinaemia (blood bilirubin level twice the upper limit of the normal range) - An increase in alanine transaminase or aspartate transaminase that is twice the upper limit of the normal range

Type de données

integer

Alias
UMLS CUI [1]
C0086565
Hyperglycemia
Description

For adults, is defined as an abnormally high level of glucose in the blood, blood glucose level that is consistently above 126mg/dL or 7 mmol/L. For children, is defined as a blood glucose level consistently above 8.3 mmol/L.

Type de données

integer

Alias
UMLS CUI [1]
C0020456
Hypoglycemia
Description

For adults, is defined as an abnormally low level of glucose in the blood, a blood glucose level that is consistently below 70mg/dL or 4 mmol/L. For children, is defined as a blood glucose level below 3 mmol/L.

Type de données

integer

Alias
UMLS CUI [1]
C0020615
Other Complications
Description

Please specify other complications in the space provided.

Type de données

integer

Alias
UMLS CUI [1,1]
C0009566
UMLS CUI [1,2]
C0205394
If you ticked "Yes" on Other Complications, please specify:
Description

Other Complications Specification

Type de données

text

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0009566
UMLS CUI [1,3]
C2348235
Diagnostics
Description

Diagnostics

Alias
UMLS CUI-1
C0430022
Was patient clinically diagnosed with COVID-19?
Description

Please record if the patient was clinically diagnosed with COVID-19, even if resources did not allow testing or if laboratory results were negative but the clinician judged that based on symptoms, onset and clinical case definitions COVID-19 infection was the most likely cause of the symptoms experienced. Please complete all of the Diagnostics section even if results were negative, to monitor co-infection risk and rates.

Type de données

integer

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0332140
Was pathogen testing done during this illness episode?
Description

If laboratory testing was done, complete the section Select YES – Confirmed if the test was positive, Yes – Probable if there was a clinical diagnosis but no positive lab test and NO if the lab test was negative. If the lab test was not done or there is no clinical diagnosis please leave blank.

Type de données

integer

Alias
UMLS CUI [1,1]
C0450254
UMLS CUI [1,2]
C0022885
UMLS CUI [1,3]
C0347984
UMLS CUI [1,4]
C0012634
UMLS CUI [1,5]
C1948053
Coronavirus
Description

If patient diagnosed with COVID-19 either confirmed or probable per definition above mark an 'X' in the box for Novel CoV.

Type de données

integer

Alias
UMLS CUI [1]
C0206422
If positive, specify:
Description

If patient diagnosed with COVID-19 either confirmed or probable per definition above mark an 'X' in the box for Novel CoV.

Type de données

integer

Alias
UMLS CUI [1,1]
C0206422
UMLS CUI [1,2]
C0449560
If you ticked "Other", please specify the subtype:
Description

Other Coronavirus Subtype

Type de données

text

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0206422
UMLS CUI [1,3]
C0449560
UMLS CUI [1,4]
C2348235
Influenza
Description

Influenza

Type de données

integer

Alias
UMLS CUI [1]
C0021400
If positive, specify:
Description

Influenza subtype

Type de données

integer

Alias
UMLS CUI [1,1]
C0021400
UMLS CUI [1,2]
C0449560
If you ticked "other", please specify the subtype:
Description

Other Influenza subtype

Type de données

text

Alias
UMLS CUI [1,1]
C0021400
UMLS CUI [1,2]
C0449560
UMLS CUI [1,3]
C2348235
RSV
Description

RSV

Type de données

integer

Alias
UMLS CUI [1]
C0035236
Adenovirus
Description

Adenovirus

Type de données

integer

Alias
UMLS CUI [1]
C0001483
Bacteria
Description

Bacteria

Type de données

integer

Alias
UMLS CUI [1]
C0004611
If positive, specify:
Description

Bacteria specification

Type de données

text

Alias
UMLS CUI [1,1]
C0004611
UMLS CUI [1,2]
C2348235
UMLS CUI [1,3]
C0370003
Bacteria: unknown
Description

Bacteria specimen unknown

Type de données

boolean

Alias
UMLS CUI [1,1]
C0004611
UMLS CUI [1,2]
C2348235
UMLS CUI [1,3]
C0439673
Other pathogen/s detected:
Description

Other pathogen/s detected

Type de données

integer

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0450254
UMLS CUI [1,3]
C0243095
If positive, specify:
Description

Other pathogen/s detected - specification

Type de données

text

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0450254
UMLS CUI [1,3]
C2348235
Pathogen: unknown
Description

Other pathogen/s detected - specimen unknown

Type de données

boolean

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0450254
UMLS CUI [1,3]
C0370003
UMLS CUI [1,4]
C0439673
Clinical pneumonia diagnosed?
Description

Tick ‘yes’ f this was a Physician diagnosis.

Type de données

integer

Alias
UMLS CUI [1]
C0543829
Chest X-Ray performed?
Description

Record if X-ray and/or CT were performed, even if no infiltrates were present.

Type de données

integer

Alias
UMLS CUI [1,1]
C0039985
UMLS CUI [1,2]
C0884358
If Chest X-Ray was performed: Were infiltrates present?
Description

Chest X-Ray: infiltrates present

Type de données

integer

Alias
UMLS CUI [1]
C2073654
CT performed?
Description

Record if X-ray and/or CT were performed, even if no infiltrates were present.

Type de données

integer

Alias
UMLS CUI [1,1]
C0040405
UMLS CUI [1,2]
C0884358
If CT was performed: Were infiltrates present?
Description

CT performed: infiltrates present

Type de données

integer

Alias
UMLS CUI [1]
C2073654
Biospecimen Testing
Description

Biospecimen Testing

Alias
UMLS CUI-1
C2347026
UMLS CUI-2
C0022885
Collection Date
Description

Collection Date

Type de données

date

Alias
UMLS CUI [1]
C1302413
Biospecimen Type
Description

If the patient had samples taken for pathogen detection testing during their hospital stay, please complete a row for every type of sample collected (e.g. nasal/NP swab, sputum, etc.). Where both positive and negative results for a particular sample type exist (from samples taken at different time points during the patient’s hospital stay) please record the earliest positive result. If only multiple negative results exist for a particular sample type (from samples taken at different time points during the patient’s hospital stay), please document the earliest negative result.

Type de données

text

Alias
UMLS CUI [1]
C2347029
If other biospecimen type, please specify
Description

Other Biospecimen Type

Type de données

text

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C2347029
UMLS CUI [1,3]
C2348235
Laboratory test method
Description

Laboratory test Method

Type de données

integer

Alias
UMLS CUI [1]
C2826902
Other laboratory test method, please specify:
Description

Other laboratory test method

Type de données

text

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C2826902
UMLS CUI [1,3]
C2348235
Laboratory Test Result
Description

Laboratory Test Result

Type de données

integer

Alias
UMLS CUI [1]
C0587081
Pathogen Tested/Detected
Description

Pathogen Tested/Detected

Type de données

text

Alias
UMLS CUI [1,1]
C0450254
UMLS CUI [1,2]
C1511790
Medication: While hospitalised or at discharge, were any of the following administered? Antiviral therapy
Description

Medication: While hospitalised or at discharge, were any of the following administered? Antiviral therapy

Alias
UMLS CUI-1
C0280274
Antiviral or COVID-19 targeted agent?
Description

Record all antivirals administered from date of admission or during the hospitalisation. Record the total number of days the treatment was given. For other antiviral or COVID-19 targeted agents record any medications given to treat COVID-19 that are not already pre-specified elsewhere in this section. Additional space is available under ‘Other treatments...’ at the end of this section if required.

Type de données

integer

Alias
UMLS CUI [1]
C0003451
UMLS CUI [2,1]
C5203670
UMLS CUI [2,2]
C2985566
If YES, specify all agents and duration:
Description

Antiviral agents administered

Type de données

integer

Alias
UMLS CUI [1,1]
C0003451
UMLS CUI [1,2]
C2348235
UMLS CUI [2,1]
C5203670
UMLS CUI [2,2]
C2985566
UMLS CUI [2,3]
C2348235
If another antiviral agent was administered, please specify:
Description

Other Antiviral agent

Type de données

text

Alias
UMLS CUI [1,1]
C0205394
UMLS CUI [1,2]
C0003451
Date commenced:
Description

Antiviral agent - Start date

Type de données

date

Alias
UMLS CUI [1,1]
C0003451
UMLS CUI [1,2]
C0808070
Duration:
Description

‘Antiviral Agent’ refers to any agent(s) prescribed to treat or prevent viral infections by interfering with the viral replication cycle. If the patient received antivirals at any time during their hospital stay, place a cross in the box marked ‘yes’ and also indicate the type of antiviral agent.

Type de données

integer

Unités de mesure
  • days
Alias
UMLS CUI [1,1]
C0003451
UMLS CUI [1,2]
C0449238
days
Duration: unknown
Description

Antiviral treatment duration unknown

Type de données

boolean

Alias
UMLS CUI [1,1]
C0003451
UMLS CUI [1,2]
C0449238
UMLS CUI [1,3]
C0439673
Medication: While hospitalised or at discharge, were any of the following administered? Antibiotic therapy
Description

Medication: While hospitalised or at discharge, were any of the following administered? Antibiotic therapy

Alias
UMLS CUI-1
C0338237
Antibiotic?
Description

‘Antibiotic’ refers to any agent(s) are substances naturally produced by microorganisms or their derivatives that selectively target microorganisms. These substances are used in the treatment of bacterial and other microbial infections. Topical preparations are not included.

Type de données

integer

Alias
UMLS CUI [1]
C0338237
Agent:
Description

‘Antibiotic’ refers to any agent(s) are substances naturally produced by microorganisms or their derivatives that selectively target microorganisms. These substances are used in the treatment of bacterial and other microbial infections. Topical preparations are not included.

Type de données

text

Alias
UMLS CUI [1]
C0338237
Date commenced:
Description

Antibiotic therapy - Date commenced

Type de données

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0338237
Duration:
Description

Antibiotic therapy - duration

Type de données

integer

Unités de mesure
  • days
Alias
UMLS CUI [1,1]
C0338237
UMLS CUI [1,2]
C0449238
days
Duration: unknown
Description

Antibiotic therapy duration unknown

Type de données

boolean

Alias
UMLS CUI [1,1]
C0338237
UMLS CUI [1,2]
C0449238
UMLS CUI [1,3]
C0439673
While hospitalised or at discharge, were any of the following administered? Corticosteriods
Description

While hospitalised or at discharge, were any of the following administered? Corticosteriods

Alias
UMLS CUI-1
C0001617
Corticosteroid?
Description

‘Corticosteroids’ (commonly referred to as ‘steroids’) refers to all types of therapeutic corticosteroid, made in the adrenal cortex (the outer part of the adrenal gland). They are also made in the laboratory. Examples include: prednisolone, prednisone, methyl- prednisolone, dexamethasone, hydrocortisone, fluticasone, betamethasone (note that other examples exist). Topical preparations are not included, but inhaled preparations are included. The indication for administering corticosteroids does not need to be directly related to the treatment of COVID-19.

Type de données

integer

Alias
UMLS CUI [1]
C0239126
If YES, Route: Oral
Description

Corticosteroid: oral route of administration

Type de données

boolean

Alias
UMLS CUI [1,1]
C1527415
UMLS CUI [1,2]
C0239126
If YES, Route: Intravenous
Description

Corticosteroid: intravenous route of administration

Type de données

boolean

Alias
UMLS CUI [1,1]
C0239126
UMLS CUI [1,2]
C1522726
f YES, Route: Inhaled
Description

Corticosteroid: inhaled route of administration

Type de données

boolean

Alias
UMLS CUI [1]
C0586793
If YES, Route: unknown
Description

Corticosteroid: unknown route of administration

Type de données

boolean

Alias
UMLS CUI [1,1]
C0239126
UMLS CUI [1,2]
C1521803
If YES Oral or IV, please provide agent:
Description

Oral oder IV Corticosteroid: agent

Type de données

text

Alias
UMLS CUI [1,1]
C1527415
UMLS CUI [1,2]
C0149783
UMLS CUI [1,3]
C2348235
UMLS CUI [2,1]
C0149783
UMLS CUI [2,2]
C2348235
UMLS CUI [2,3]
C1621368
If YES Oral or IV, please provide max. daily dose & unit:
Description

Oral oder IV Corticosteroid: dosage and unit

Type de données

text

Alias
UMLS CUI [1,1]
C1527415
UMLS CUI [1,2]
C0239126
UMLS CUI [1,3]
C0806909
UMLS CUI [1,4]
C2348070
UMLS CUI [2,1]
C0239126
UMLS CUI [2,2]
C1621368
UMLS CUI [2,3]
C0806909
UMLS CUI [2,4]
C2348070
UMLS CUI [3,1]
C1527415
UMLS CUI [3,2]
C0239126
UMLS CUI [3,3]
C2348328
UMLS CUI [4,1]
C0239126
UMLS CUI [4,2]
C1621368
UMLS CUI [4,3]
C2348328
Date commenced:
Description

Corticosteroid - Start date

Type de données

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0149783
Date of commencement: unknown
Description

Corticosteroid - Start date unknown

Type de données

boolean

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0149783
UMLS CUI [1,3]
C0439673
Duration:
Description

Corticosteroid therapy duration

Type de données

integer

Unités de mesure
  • days
Alias
UMLS CUI [1,1]
C0149783
UMLS CUI [1,2]
C0449238
days
Duration: unknown
Description

Corticosteroid therapy duration unknown

Type de données

boolean

Alias
UMLS CUI [1,1]
C0449238
UMLS CUI [1,2]
C0149783
UMLS CUI [1,3]
C0439673
Medication: While hospitalised or at discharge, were any of the following administered? Heparin
Description

Medication: While hospitalised or at discharge, were any of the following administered? Heparin

Alias
UMLS CUI-1
C0019134
Heparin?
Description

Heparin

Type de données

integer

Alias
UMLS CUI [1,1]
C0019134
UMLS CUI [1,2]
C1533734
If YES, Route: Subcutaneous
Description

Heparin - Subcutaneous route of administration

Type de données

boolean

Alias
UMLS CUI [1,1]
C0019134
UMLS CUI [1,2]
C1522438
If YES, Route: Intravenous (IV)
Description

Heparin - Intravenous (IV) route of administration

Type de données

boolean

Alias
UMLS CUI [1,1]
C0019134
UMLS CUI [1,2]
C1522726
If YES, Route: Unknown
Description

Heparin - unknown route of administration

Type de données

boolean

Alias
UMLS CUI [1,1]
C0019134
UMLS CUI [1,2]
C1521803
If YES: Unfractionated
Description

Unfractionated heparin

Type de données

boolean

Alias
UMLS CUI [1]
C2825026
If YES: Low molecular weight heparin
Description

Heparin type - Low molecular weight

Type de données

boolean

Alias
UMLS CUI [1]
C0019139
If YES: Fondaparinux
Description

Fondaparinux

Type de données

boolean

Alias
UMLS CUI [1]
C1098510
If YES: Heparin type unknown
Description

Heparin type unknown

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332307
UMLS CUI [1,2]
C0019134
UMLS CUI [1,3]
C0439673
If Heparin was administered, please provide max. daily dose & unit:
Description

Heparin dosage and unit

Type de données

text

Alias
UMLS CUI [1,1]
C0806909
UMLS CUI [1,2]
C2348070
UMLS CUI [1,3]
C0019134
UMLS CUI [2,1]
C2348328
UMLS CUI [2,2]
C0019134
Date commenced:
Description

Heparin - Start date

Type de données

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0019134
Date of commencement: unknown
Description

Heparin - Start date unknown

Type de données

boolean

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C0019134
UMLS CUI [1,3]
C0439673
Duration:
Description

Heparin therapy duration

Type de données

integer

Unités de mesure
  • days
Alias
UMLS CUI [1,1]
C0449238
UMLS CUI [1,2]
C0019134
days
Duration: unknown
Description

Heparin therapy duration unknown

Type de données

boolean

Alias
UMLS CUI [1,1]
C0449238
UMLS CUI [1,2]
C0019134
UMLS CUI [1,3]
C0439673
Medication: While hospitalised or at discharge, were any of the following administered? Antifungal therapy
Description

Medication: While hospitalised or at discharge, were any of the following administered? Antifungal therapy

Alias
UMLS CUI-1
C0678026
Antifungal agent?
Description

‘Antifungal agent’ refers to any agent(s) prescribed specifically to treat systemic or topical infections caused by fungi. Examples include fluconazole, amphotericin, caspofungin, anidulafungin, posaconazole, itraconazole (note that other examples exist). Topical preparations should not be recorded.

Type de données

integer

Alias
UMLS CUI [1]
C0003308
Medication: While hospitalised or at discharge, were any of the following administered? Other treatments administered for COVID-19
Description

Medication: While hospitalised or at discharge, were any of the following administered? Other treatments administered for COVID-19

Alias
UMLS CUI-1
C5203670
UMLS CUI-2
C0205394
UMLS CUI-3
C0013227
Other treatments administered for COVID-19 including experimental or compassionate use?
Description

Record any other medications, experimental or re-purposed, administered to modify the course of COVID-19 during the admission (including as part of a clinical trial). This could include convalescent plasma, immuno-modulatory agents and anti-viral agents not already recorded above.

Type de données

integer

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0013227
UMLS CUI [2,1]
C0304229
UMLS CUI [2,2]
C5203670
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C2718016
UMLS CUI [3,3]
C5203670
If yes, specify agent:
Description

Other treatments administered for COVID-19

Type de données

text

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0013227
If another treatment was administered, please provide max. daily dose & unit:
Description

Other treatment for COVID-19: dosage and unit

Type de données

text

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0013227
UMLS CUI [1,4]
C0806909
UMLS CUI [1,5]
C2348070
UMLS CUI [2,1]
C5203670
UMLS CUI [2,2]
C0205394
UMLS CUI [2,3]
C0013227
UMLS CUI [2,4]
C2348328
Date of commencement
Description

Other treatment for COVID-19: Date of commencement

Type de données

date

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0013227
UMLS CUI [1,4]
C0808070
Date of commencement: unknown
Description

Other treatment for COVID-19: Date of commencement known

Type de données

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0013227
UMLS CUI [1,4]
C0808070
UMLS CUI [1,5]
C0439673
Duration of other treatment for COVID-19
Description

Other treatment for COVID-19: Duration of therapy

Type de données

integer

Unités de mesure
  • days
Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0013227
UMLS CUI [1,4]
C0449238
days
Duration of other treatment for COVID-19 known
Description

Other treatment for COVID-19: Duration of therapy known

Type de données

boolean

Alias
UMLS CUI [1,1]
C5203670
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C0013227
UMLS CUI [1,4]
C0449238
Outcome
Description

Outcome

Alias
UMLS CUI-1
C1547647
Please select only one outcome
Description

Discharged alive can mean discharge to their usual place of residence before their illness, to the home of a relative or friend, or to a social care facility, because their illness is no longer severe enough to warrant treatment in a medical facility. Hospitalized means they are still in hospital but have recovered from COVID-19 infection and the form has been completed as the patient is in a part of the hospital for care of other conditions and where the form will not be completed at a later date. Transfer to other facility means they have been transferred to another facility that provides medical care. This could be a specialist centre for more intensive treatment or a step-down for rehabilitation. It does not include facilities that solely provide social care (these patients should be listed as discharged alive). Death means the patient died in the hospital. Palliative discharge means the patient has been discharged with the expectation that they will not recover from this or other co-existing illness. This could be to a specialist hospice facility, or to their usual home address with anticipatory end of life medications.

Type de données

integer

Alias
UMLS CUI [1]
C1547647
Outcome date
Description

Please state the date for the outcome listed above.

Type de données

date

Alias
UMLS CUI [1,1]
C1547647
UMLS CUI [1,2]
C0011008
Outcome date: unknown
Description

Please state the date for the outcome listed above.

Type de données

boolean

Alias
UMLS CUI [1,1]
C1547647
UMLS CUI [1,2]
C0011008
UMLS CUI [1,3]
C0439673
If Discharged alive: Ability to self-care at discharge versus before illness
Description

Ability to self-care at discharge versus before illness: the patient is able to care for themselves at discharge (in terms of activities of daily living) at the same level as before they developed illness then tick ‘same as before illness’. If their ability to self-care has decreased or increased, then tick the appropriate circle (‘worse’ or ‘better’).

Type de données

integer

Alias
UMLS CUI [1,1]
C0562734
UMLS CUI [1,2]
C3871203
If Discharged alive: Post-discharge treatment - Oxygen therapy?
Description

(Complete this section only if the patient is alive) Oxygen therapy includes, NIV or home ventilation (respiratory support/treatment).

Type de données

integer

Alias
UMLS CUI [1,1]
C0586003
UMLS CUI [1,2]
C0687676
UMLS CUI [1,3]
C0184633

Similar models

MODULE 3: OUTCOME CASE REPORT FORM

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Participant Identification
C3165543 (UMLS CUI-1)
Participant Identification Numbers
Item
Participant Identification Numbers
text
C3165543 (UMLS CUI [1])
Item Group
At ANY time during hospitalisation, did the patient receive/undergo:
C0087111 (UMLS CUI-1)
Item
Any Oxygen therapy?
integer
C0184633 (UMLS CUI [1])
Code List
Any Oxygen therapy?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Oxygen therapy duration
Item
If YES, total duration:
integer
C0184633 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Oxygen therapy duration unknown
Item
Total duration: unknown
boolean
C0184633 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
Item
Maximum O2 flow volume:
integer
C1960999 (UMLS CUI [1])
Code List
Maximum O2 flow volume:
CL Item
<2 L/min (1)
CL Item
2-5 L/min (2)
CL Item
6-10 L/min (3)
CL Item
11-15 L/min (4)
CL Item
>15 L/min (5)
Item
Non-invasive ventilation? (Any)
integer
C1997883 (UMLS CUI [1])
Code List
Non-invasive ventilation? (Any)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Non-invasive ventilation duration
Item
If YES, total duration:
integer
C1997883 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Non-invasive ventilation duration unknown
Item
Total duration: unknown
boolean
C1997883 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
Item
Invasive ventilation (Any)?
integer
C1868981 (UMLS CUI [1])
Code List
Invasive ventilation (Any)?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Invasive ventilation duration
Item
If YES, total duration:
integer
C1868981 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Invasive ventilation duration unknown
Item
Total duration: unknown
boolean
C1868981 (UMLS CUI [1,1])
C0439673 (UMLS CUI [1,2])
Item
Prone Positioning?
integer
C0808387 (UMLS CUI [1,1])
C0033422 (UMLS CUI [1,2])
Code List
Prone Positioning?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Prone positioning duration
Item
If YES, total duration:
integer
C0808387 (UMLS CUI [1,1])
C0033422 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
Prone positioning duration unknown
Item
Total duration: unknown
boolean
C0808387 (UMLS CUI [1,1])
C0033422 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C0439673 (UMLS CUI [1,4])
Item
Inhaled Nitric Oxide?
integer
C1135443 (UMLS CUI [1])
Code List
Inhaled Nitric Oxide?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Tracheostomy inserted?
integer
C0040590 (UMLS CUI [1])
Code List
Tracheostomy inserted?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Extracorporeal support?
integer
C4068956 (UMLS CUI [1])
Code List
Extracorporeal support?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Extracorporeal support duration
Item
If YES, total duration:
integer
C4068956 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Extracorporeal support duration unknown
Item
Total duration: unknown
boolean
C4068956 (UMLS CUI [1,1])
C0439673 (UMLS CUI [1,2])
Item
Renal replacement therapy (RRT) or dialysis?
integer
C0206074 (UMLS CUI [1])
C0011946 (UMLS CUI [2])
Code List
Renal replacement therapy (RRT) or dialysis?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Inotropes/vasopressors?
integer
C0304509 (UMLS CUI [1])
C0042397 (UMLS CUI [2])
Code List
Inotropes/vasopressors?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Inotropes/vasopressors duration
Item
If YES, total duration:
integer
C0042397 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0304509 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
C2348235 (UMLS CUI [2,3])
Inotropes/vasopressors duration unknown
Item
Total duration: unknown
boolean
C0304509 (UMLS CUI [1,1])
C0439673 (UMLS CUI [1,2])
C0042397 (UMLS CUI [2,1])
C0439673 (UMLS CUI [2,2])
Item
ICU or High Dependency Unit admission?
integer
C0583239 (UMLS CUI [1])
C1301858 (UMLS CUI [2])
Code List
ICU or High Dependency Unit admission?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Total duration of ICU/High Dependency stay
Item
If YES, total duration:
integer
C1627345 (UMLS CUI [1,1])
C0444921 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0021708 (UMLS CUI [2,1])
C0444921 (UMLS CUI [2,2])
C2348235 (UMLS CUI [2,3])
Total duration of ICU/High Dependency stay unknown
Item
Total duration: unknown
boolean
C1627345 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0021708 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
C0439673 (UMLS CUI [2,3])
Date of ICU admission
Item
If YES, date of ICU admission
date
C0583239 (UMLS CUI [1,1])
C1302393 (UMLS CUI [1,2])
C1301858 (UMLS CUI [2,1])
C1302393 (UMLS CUI [2,2])
Date of ICU admission unknown
Item
Date of ICU admission: unknown
boolean
C0583239 (UMLS CUI [1,1])
C1302393 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C1301858 (UMLS CUI [2,1])
C1302393 (UMLS CUI [2,2])
C0439673 (UMLS CUI [2,3])
Date of ICU discharge
Item
If YES, date of ICU discharge:
date
C1627345 (UMLS CUI [1,1])
C2361123 (UMLS CUI [1,2])
C0021708 (UMLS CUI [2,1])
C2361123 (UMLS CUI [2,2])
Date of ICU discharge unknown
Item
Date of ICU discharge: unknown
date
C1627345 (UMLS CUI [1,1])
C2361123 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0021708 (UMLS CUI [2,1])
C2361123 (UMLS CUI [2,2])
C0439673 (UMLS CUI [2,3])
Item Group
At any time during hospitalisation did the patient experience
C0009566 (UMLS CUI-1)
Item
Viral pneumonitis
integer
C0032310 (UMLS CUI [1])
Code List
Viral pneumonitis
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Bacterial pneumonia
integer
C0004626 (UMLS CUI [1])
Code List
Bacterial pneumonia
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Acute Respiratory Distress Syndrome
integer
C4534309 (UMLS CUI [1])
Code List
Acute Respiratory Distress Syndrome
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
If you ticked "Yes" on Acute Respiratory Distress Syndrome, please specify the severity:
integer
C4534309 (UMLS CUI [1,1])
C0439793 (UMLS CUI [1,2])
Code List
If you ticked "Yes" on Acute Respiratory Distress Syndrome, please specify the severity:
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe  (3)
CL Item
Unknown (4)
Item
Pneumothorax
integer
C0032326 (UMLS CUI [1])
Code List
Pneumothorax
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Pleural effusion
integer
C1253943 (UMLS CUI [1])
Code List
Pleural effusion
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Cryptogenic organizing pneumonia (COP)
integer
C0242770 (UMLS CUI [1])
Code List
Cryptogenic organizing pneumonia (COP)
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Bronchiolitis
integer
C0006271 (UMLS CUI [1])
Code List
Bronchiolitis
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Cardiac arrest
integer
C0018790 (UMLS CUI [1])
Code List
Cardiac arrest
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Myocardial infarction
integer
C0027051 (UMLS CUI [1])
Code List
Myocardial infarction
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Cardiac ischaemia
integer
C0151744 (UMLS CUI [1])
Code List
Cardiac ischaemia
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Cardiac arrhythmia
integer
C0003811 (UMLS CUI [1])
Code List
Cardiac arrhythmia
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Myocarditis / Pericarditis
integer
C0027059 (UMLS CUI [1])
C0031046 (UMLS CUI [2])
Code List
Myocarditis / Pericarditis
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Endocarditis
integer
C0014118 (UMLS CUI [1])
Code List
Endocarditis
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Cardiomyopathy
integer
C0878544 (UMLS CUI [1])
Code List
Cardiomyopathy
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Congestive heart failure
integer
C0018802 (UMLS CUI [1])
Code List
Congestive heart failure
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Seizure
integer
C0036572 (UMLS CUI [1])
Code List
Seizure
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Stroke / Cerebrovascular accident
integer
C0038454 (UMLS CUI [1])
Code List
Stroke / Cerebrovascular accident
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Meningitis / Encephalitis
integer
C0497299 (UMLS CUI [1])
Code List
Meningitis / Encephalitis
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Bacteremia
integer
C0004610 (UMLS CUI [1])
Code List
Bacteremia
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Coagulation disorder / Disseminated Intravascular Coagulation
integer
C0012739 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
Code List
Coagulation disorder / Disseminated Intravascular Coagulation
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Pulmonary embolism
integer
C0034065 (UMLS CUI [1])
Code List
Pulmonary embolism
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Anemia
integer
C0002871 (UMLS CUI [1])
Code List
Anemia
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Rhabdomyolysis / Myositis
integer
C0035410 (UMLS CUI [1])
C0027121 (UMLS CUI [2])
Code List
Rhabdomyolysis / Myositis
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Acute renal injury/ Acute renal failure
integer
C0022660 (UMLS CUI [1])
C2609414 (UMLS CUI [2])
Code List
Acute renal injury/ Acute renal failure
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Gastrointestinal haemorrhage
integer
C0017181 (UMLS CUI [1])
Code List
Gastrointestinal haemorrhage
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Pancreatitis
integer
C0030305 (UMLS CUI [1])
Code List
Pancreatitis
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Liver dysfunction
integer
C0086565 (UMLS CUI [1])
Code List
Liver dysfunction
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Hyperglycemia
integer
C0020456 (UMLS CUI [1])
Code List
Hyperglycemia
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Hypoglycemia
integer
C0020615 (UMLS CUI [1])
Code List
Hypoglycemia
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Other Complications
integer
C0009566 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Code List
Other Complications
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Other Complications Specification
Item
If you ticked "Yes" on Other Complications, please specify:
text
C0205394 (UMLS CUI [1,1])
C0009566 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Item Group
Diagnostics
C0430022 (UMLS CUI-1)
Item
Was patient clinically diagnosed with COVID-19?
integer
C5203670 (UMLS CUI [1,1])
C0332140 (UMLS CUI [1,2])
Code List
Was patient clinically diagnosed with COVID-19?
CL Item
Yes  (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Was pathogen testing done during this illness episode?
integer
C0450254 (UMLS CUI [1,1])
C0022885 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0012634 (UMLS CUI [1,4])
C1948053 (UMLS CUI [1,5])
Code List
Was pathogen testing done during this illness episode?
CL Item
Yes (complete section) (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Coronavirus
integer
C0206422 (UMLS CUI [1])
Code List
Coronavirus
CL Item
Positive (1)
CL Item
Negative (2)
CL Item
Not done (3)
Item
If positive, specify:
integer
C0206422 (UMLS CUI [1,1])
C0449560 (UMLS CUI [1,2])
Code List
If positive, specify:
CL Item
COVID-2019/ SARS-CoV2 (1)
CL Item
MERS CoV (2)
CL Item
Other CoV (3)
CL Item
Unknown (4)
Other Coronavirus Subtype
Item
If you ticked "Other", please specify the subtype:
text
C0205394 (UMLS CUI [1,1])
C0206422 (UMLS CUI [1,2])
C0449560 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
Item
Influenza
integer
C0021400 (UMLS CUI [1])
CL Item
Positive (1)
CL Item
Negative (2)
CL Item
Not done (3)
Item
If positive, specify:
integer
C0021400 (UMLS CUI [1,1])
C0449560 (UMLS CUI [1,2])
Code List
If positive, specify:
CL Item
A/H3N2 (1)
CL Item
A/H1N1pdm09 (2)
CL Item
A/H7N9 (3)
CL Item
A/H5N1 (4)
CL Item
A, not typed (5)
CL Item
B (6)
CL Item
Other (7)
CL Item
Unknown (8)
Other Influenza subtype
Item
If you ticked "other", please specify the subtype:
text
C0021400 (UMLS CUI [1,1])
C0449560 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Item
RSV
integer
C0035236 (UMLS CUI [1])
CL Item
Positive (1)
CL Item
Negative (2)
CL Item
Not done (3)
Item
Adenovirus
integer
C0001483 (UMLS CUI [1])
CL Item
Positive (1)
CL Item
Negative (2)
CL Item
Not done (3)
Item
Bacteria
integer
C0004611 (UMLS CUI [1])
CL Item
Positive (1)
CL Item
Negative (2)
CL Item
Not done (3)
Bacteria specification
Item
If positive, specify:
text
C0004611 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
C0370003 (UMLS CUI [1,3])
Bacteria specimen unknown
Item
Bacteria: unknown
boolean
C0004611 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
Item
Other pathogen/s detected:
integer
C0205394 (UMLS CUI [1,1])
C0450254 (UMLS CUI [1,2])
C0243095 (UMLS CUI [1,3])
Code List
Other pathogen/s detected:
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Other pathogen/s detected - specification
Item
If positive, specify:
text
C0205394 (UMLS CUI [1,1])
C0450254 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Other pathogen/s detected - specimen unknown
Item
Pathogen: unknown
boolean
C0205394 (UMLS CUI [1,1])
C0450254 (UMLS CUI [1,2])
C0370003 (UMLS CUI [1,3])
C0439673 (UMLS CUI [1,4])
Item
Clinical pneumonia diagnosed?
integer
C0543829 (UMLS CUI [1])
Code List
Clinical pneumonia diagnosed?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
Chest X-Ray performed?
integer
C0039985 (UMLS CUI [1,1])
C0884358 (UMLS CUI [1,2])
Code List
Chest X-Ray performed?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
If Chest X-Ray was performed: Were infiltrates present?
integer
C2073654 (UMLS CUI [1])
Code List
If Chest X-Ray was performed: Were infiltrates present?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
CT performed?
integer
C0040405 (UMLS CUI [1,1])
C0884358 (UMLS CUI [1,2])
Code List
CT performed?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
If CT was performed: Were infiltrates present?
integer
C2073654 (UMLS CUI [1])
Code List
If CT was performed: Were infiltrates present?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Biospecimen Testing
C2347026 (UMLS CUI-1)
C0022885 (UMLS CUI-2)
Collection Date
Item
Collection Date
date
C1302413 (UMLS CUI [1])
Item
Biospecimen Type
text
C2347029 (UMLS CUI [1])
Code List
Biospecimen Type
CL Item
Nasal/NP swab (1)
CL Item
Throat swab (2)
CL Item
Combined nasal/NP+throat swab (3)
CL Item
Sputum (4)
CL Item
BAL (5)
CL Item
ETA (6)
CL Item
Urine (7)
CL Item
Feces/rectal swab (8)
CL Item
Blood (9)
CL Item
Other (10)
Other Biospecimen Type
Item
If other biospecimen type, please specify
text
C0205394 (UMLS CUI [1,1])
C2347029 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Item
Laboratory test method
integer
C2826902 (UMLS CUI [1])
Code List
Laboratory test method
CL Item
PCR (1)
CL Item
Culture (2)
CL Item
Other (3)
Other laboratory test method
Item
Other laboratory test method, please specify:
text
C0205394 (UMLS CUI [1,1])
C2826902 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Item
Laboratory Test Result
integer
C0587081 (UMLS CUI [1])
Code List
Laboratory Test Result
CL Item
Positive (1)
CL Item
Negative (2)
CL Item
Unknown (3)
Pathogen Tested/Detected
Item
Pathogen Tested/Detected
text
C0450254 (UMLS CUI [1,1])
C1511790 (UMLS CUI [1,2])
Item Group
Medication: While hospitalised or at discharge, were any of the following administered? Antiviral therapy
C0280274 (UMLS CUI-1)
Item
Antiviral or COVID-19 targeted agent?
integer
C0003451 (UMLS CUI [1])
C5203670 (UMLS CUI [2,1])
C2985566 (UMLS CUI [2,2])
Code List
Antiviral or COVID-19 targeted agent?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item
If YES, specify all agents and duration:
integer
C0003451 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
C5203670 (UMLS CUI [2,1])
C2985566 (UMLS CUI [2,2])
C2348235 (UMLS CUI [2,3])
Code List
If YES, specify all agents and duration:
CL Item
Ribavirin (1)
CL Item
Lopinavir/Ritonavir (2)
CL Item
Remdesivir (3)
CL Item
Interferon alpha (4)
CL Item
Interferon beta (5)
CL Item
Chloroquine/hydroxychloroquine (6)
CL Item
Other (7)
Other Antiviral agent
Item
If another antiviral agent was administered, please specify:
text
C0205394 (UMLS CUI [1,1])
C0003451 (UMLS CUI [1,2])
Antiviral agent - Start date
Item
Date commenced:
date
C0003451 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Antiviral treatment duration
Item
Duration:
integer
C0003451 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Antiviral treatment duration unknown
Item
Duration: unknown
boolean
C0003451 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
Item Group
Medication: While hospitalised or at discharge, were any of the following administered? Antibiotic therapy
C0338237 (UMLS CUI-1)
Item
Antibiotic?
integer
C0338237 (UMLS CUI [1])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Antibiotic
Item
Agent:
text
C0338237 (UMLS CUI [1])
Antibiotic therapy - Date commenced
Item
Date commenced:
date
C0808070 (UMLS CUI [1,1])
C0338237 (UMLS CUI [1,2])
Antibiotic therapy - duration
Item
Duration:
integer
C0338237 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Antibiotic therapy duration unknown
Item
Duration: unknown
boolean
C0338237 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
Item Group
While hospitalised or at discharge, were any of the following administered? Corticosteriods
C0001617 (UMLS CUI-1)
Item
Corticosteroid?
integer
C0239126 (UMLS CUI [1])
Code List
Corticosteroid?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Corticosteroid: oral route of administration
Item
If YES, Route: Oral
boolean
C1527415 (UMLS CUI [1,1])
C0239126 (UMLS CUI [1,2])
Corticosteroid: intravenous route of administration
Item
If YES, Route: Intravenous
boolean
C0239126 (UMLS CUI [1,1])
C1522726 (UMLS CUI [1,2])
Corticosteroid: inhaled route of administration
Item
f YES, Route: Inhaled
boolean
C0586793 (UMLS CUI [1])
Corticosteroid: unknown route of administration
Item
If YES, Route: unknown
boolean
C0239126 (UMLS CUI [1,1])
C1521803 (UMLS CUI [1,2])
Oral oder IV Corticosteroid: agent
Item
If YES Oral or IV, please provide agent:
text
C1527415 (UMLS CUI [1,1])
C0149783 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0149783 (UMLS CUI [2,1])
C2348235 (UMLS CUI [2,2])
C1621368 (UMLS CUI [2,3])
Oral oder IV Corticosteroid: dosage and unit
Item
If YES Oral or IV, please provide max. daily dose & unit:
text
C1527415 (UMLS CUI [1,1])
C0239126 (UMLS CUI [1,2])
C0806909 (UMLS CUI [1,3])
C2348070 (UMLS CUI [1,4])
C0239126 (UMLS CUI [2,1])
C1621368 (UMLS CUI [2,2])
C0806909 (UMLS CUI [2,3])
C2348070 (UMLS CUI [2,4])
C1527415 (UMLS CUI [3,1])
C0239126 (UMLS CUI [3,2])
C2348328 (UMLS CUI [3,3])
C0239126 (UMLS CUI [4,1])
C1621368 (UMLS CUI [4,2])
C2348328 (UMLS CUI [4,3])
Corticosteroid - Start date
Item
Date commenced:
date
C0808070 (UMLS CUI [1,1])
C0149783 (UMLS CUI [1,2])
Corticosteroid - Start date unknown
Item
Date of commencement: unknown
boolean
C0808070 (UMLS CUI [1,1])
C0149783 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
Corticosteroid therapy duration
Item
Duration:
integer
C0149783 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Corticosteroid therapy duration unknown
Item
Duration: unknown
boolean
C0449238 (UMLS CUI [1,1])
C0149783 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
Item Group
Medication: While hospitalised or at discharge, were any of the following administered? Heparin
C0019134 (UMLS CUI-1)
Item
Heparin?
integer
C0019134 (UMLS CUI [1,1])
C1533734 (UMLS CUI [1,2])
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Heparin - Subcutaneous route of administration
Item
If YES, Route: Subcutaneous
boolean
C0019134 (UMLS CUI [1,1])
C1522438 (UMLS CUI [1,2])
Heparin - Intravenous (IV) route of administration
Item
If YES, Route: Intravenous (IV)
boolean
C0019134 (UMLS CUI [1,1])
C1522726 (UMLS CUI [1,2])
Heparin - unknown route of administration
Item
If YES, Route: Unknown
boolean
C0019134 (UMLS CUI [1,1])
C1521803 (UMLS CUI [1,2])
Unfractionated heparin
Item
If YES: Unfractionated
boolean
C2825026 (UMLS CUI [1])
Heparin type - Low molecular weight
Item
If YES: Low molecular weight heparin
boolean
C0019139 (UMLS CUI [1])
Fondaparinux
Item
If YES: Fondaparinux
boolean
C1098510 (UMLS CUI [1])
Heparin type unknown
Item
If YES: Heparin type unknown
boolean
C0332307 (UMLS CUI [1,1])
C0019134 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
Heparin dosage and unit
Item
If Heparin was administered, please provide max. daily dose & unit:
text
C0806909 (UMLS CUI [1,1])
C2348070 (UMLS CUI [1,2])
C0019134 (UMLS CUI [1,3])
C2348328 (UMLS CUI [2,1])
C0019134 (UMLS CUI [2,2])
Heparin - Start date
Item
Date commenced:
date
C0808070 (UMLS CUI [1,1])
C0019134 (UMLS CUI [1,2])
Heparin - Start date unknown
Item
Date of commencement: unknown
boolean
C0808070 (UMLS CUI [1,1])
C0019134 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
Heparin therapy duration
Item
Duration:
integer
C0449238 (UMLS CUI [1,1])
C0019134 (UMLS CUI [1,2])
Heparin therapy duration unknown
Item
Duration: unknown
boolean
C0449238 (UMLS CUI [1,1])
C0019134 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
Item Group
Medication: While hospitalised or at discharge, were any of the following administered? Antifungal therapy
C0678026 (UMLS CUI-1)
Item
Antifungal agent?
integer
C0003308 (UMLS CUI [1])
Code List
Antifungal agent?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Item Group
Medication: While hospitalised or at discharge, were any of the following administered? Other treatments administered for COVID-19
C5203670 (UMLS CUI-1)
C0205394 (UMLS CUI-2)
C0013227 (UMLS CUI-3)
Item
Other treatments administered for COVID-19 including experimental or compassionate use?
integer
C5203670 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0304229 (UMLS CUI [2,1])
C5203670 (UMLS CUI [2,2])
C0013227 (UMLS CUI [3,1])
C2718016 (UMLS CUI [3,2])
C5203670 (UMLS CUI [3,3])
Code List
Other treatments administered for COVID-19 including experimental or compassionate use?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Other treatments administered for COVID-19
Item
If yes, specify agent:
text
C5203670 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
Other treatment for COVID-19: dosage and unit
Item
If another treatment was administered, please provide max. daily dose & unit:
text
C5203670 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0806909 (UMLS CUI [1,4])
C2348070 (UMLS CUI [1,5])
C5203670 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
C0013227 (UMLS CUI [2,3])
C2348328 (UMLS CUI [2,4])
Other treatment for COVID-19: Date of commencement
Item
Date of commencement
date
C5203670 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0808070 (UMLS CUI [1,4])
Other treatment for COVID-19: Date of commencement known
Item
Date of commencement: unknown
boolean
C5203670 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0808070 (UMLS CUI [1,4])
C0439673 (UMLS CUI [1,5])
Other treatment for COVID-19: Duration of therapy
Item
Duration of other treatment for COVID-19
integer
C5203670 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,4])
Other treatment for COVID-19: Duration of therapy known
Item
Duration of other treatment for COVID-19 known
boolean
C5203670 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,4])
Item Group
Outcome
C1547647 (UMLS CUI-1)
Item
Please select only one outcome
integer
C1547647 (UMLS CUI [1])
Code List
Please select only one outcome
CL Item
Discharged alive (1)
CL Item
Hospitalization (2)
CL Item
Transfer to other facility (3)
CL Item
Death (4)
CL Item
Palliative discharge (5)
CL Item
Unknown (6)
Outcome date
Item
Outcome date
date
C1547647 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Outcome date unknown
Item
Outcome date: unknown
boolean
C1547647 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
Item
If Discharged alive: Ability to self-care at discharge versus before illness
integer
C0562734 (UMLS CUI [1,1])
C3871203 (UMLS CUI [1,2])
Code List
If Discharged alive: Ability to self-care at discharge versus before illness
CL Item
Same as before illness (1)
CL Item
Worse (2)
CL Item
Better (3)
CL Item
Unknown (4)
Item
If Discharged alive: Post-discharge treatment - Oxygen therapy?
integer
C0586003 (UMLS CUI [1,1])
C0687676 (UMLS CUI [1,2])
C0184633 (UMLS CUI [1,3])
Code List
If Discharged alive: Post-discharge treatment - Oxygen therapy?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial